Know Labs, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
USBC, Inc. announces a $125 million capital investment and the launch of its innovative U.S. dollar-denominated, identity-embedded, blockchain-based deposit token, ahead of its 2025 Annual Stockholders Meeting.
Know Labs, Inc. has adjourned its Special Shareholder Meeting to July 31, 2025, urging stockholders to vote FOR all proposals before the July 30, 2025 deadline.
Know Labs, Inc. has engaged Laurel Hill Advisory Group, LLC to assist with proxy solicitation for its Special Meeting of Stockholders scheduled for July 31, 2025.
Know Labs, Inc. has adjourned its Special Meeting of Stockholders to July 31, 2025, to provide additional time for stockholders to vote on all proposals.
Know Labs, Inc. reminds stockholders to cast their votes for the upcoming Special Meeting on July 24, 2025, emphasizing the Board's unanimous recommendation for all proposals.
Know Labs, Inc. is calling a special shareholder meeting to approve a significant increase in authorized common stock, a private placement of up to $119.9 million, and an expansion of its equity incentive plan, all critical to avoid potential cessation of operations and bankruptcy.
Know Labs is asking shareholders to approve a reverse stock split of up to 1-for-15 to maintain its listing on the NYSE American and potentially attract new investors.
DEF 14A: Know Labs Seeks Stockholder Approval for Share Increase and Equity Incentive Plan Amendment
Know Labs is asking stockholders to vote on proposals to increase the number of authorized common shares and amend the equity incentive plan at a special meeting on October 25, 2024.
Know Labs, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on September 26, 2024, to vote on director elections, auditor ratification, share issuance authorization, and executive compensation.